Degenerative Disc Disease clinical trials at UCSF

1 in progress, 0 open to eligible people

Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain
Sorry, in progress, not accepting new patients
The primary purpose of this study is to evaluate the efficacy of rexlemestrocel-L+HA compared to control in reducing low back pain at 12 months post-treatment and safety of a single injection of rexlemestrocel-L+HA injected into a lumbar intervertebral disc compared to control through 12 months post-treatment.
San Francisco, California and other locations

Last updated: June 15, 2026

Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain